-
- FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor
- Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has approved PIMJETMI® (pimicotinib), a once-daily oral colony stimulating factor-1 receptor (CSF-1R) inhibitor, as a systemic treatm...
- 15:50
-
- Nearly Nine in 10 Private Capital GPs Face Data Validation Challenges
- Nearly nine in 10 (88%) of private capital general partners (GPs) surveyed say their finance and operations teams spend between 11% and 50% of their time validating, reconciling, recalculating or recreating administrator outputs, according to new ...
- 15:15
